At a glance
ClinicalIndex Comparison RecordN/ACompleted· 69 enrolled
Drug / intervention
Lactobacillus reuteri DSM17038 +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Influence of Lactobacillus Reuteri DSM17938 on Early Gut Microbial Colonization in Infants Born by Caesarean Section: A Double-blinded, Randomized, Placebo-controlled Study
Innovacion y Desarrollo de Estrategias en Salud·interventional·Posted Feb 8, 2019·Updated Jun 20, 2019
In Brief
A clinical study evaluating Lactobacillus reuteri DSM17038 and Placebo for Probiotics for C-section. Completed, enrolled 69 participants across 1 site.
Detailed Summary
RCT designed to evaluate the impact of Lactobacillus reuteri DSM17938 to modify gut microbiota in children delivered by C-section
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsC-section
CountriesMexico
CollaboratorsBioGaia AB
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 2019
Enrollment StartFeb 2019
Primary CompletionApr 2019
Study CompletionJun 2019
TodayJul 2026
First PostedFeb 8, 2019
Enrollment StartFeb 8, 2019
Primary CompletionApr 18, 2019
Study CompletionJun 18, 2019
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 7.4 years ago
Interventions
Lactobacillus reuteri DSM17038dietary
Oil drops of L. reuteri containing 1x10\>8 CFU
Placebo for Probioticsother
Oil drops mimicking in consistency and flavor to experimental product